Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare
Denali Therapeutics Inc. Cash on Hand 2016–2025
Denali Therapeutics Inc. annual cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Denali Therapeutics Inc. cash on hand as of December 31, 2025: 205.3M, a 17.36% increase year-over-year.
- Denali Therapeutics Inc. cash on hand for 2025 were 205.3M, a 17.36% increase from 2024.
- Denali Therapeutics Inc. cash on hand for 2024 were 175.0M, a 37.65% increase from 2023.
- Denali Therapeutics Inc. cash on hand for 2023 were 127.1M, a 41.71% decrease from 2022.
- Denali Therapeutics Inc. cash on hand for 2022 were 218.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Denali Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $205 |
| 2024 | $175 |
| 2023 | $127 |
| 2022 | $218 |
| 2021 | $293 |
| 2020 | $507 |
| 2019 | $79 |
| 2018 | $77 |
| 2017 | $218 |
Denali Therapeutics Inc. Cash on Hand — FAQ
Denali Therapeutics Inc. (DNLI) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNLI's cash on hand history?
The chart and table above show Denali Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.